Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sensitivity analysis of longitudinal normal data with drop-outs.

Pascal Minini1, Michel Chavance

  • 1Laboratoire GlaxoSmithKline, Unité Méthodologie et Biostatistique, 100 route de Versailles, 78163 Marly le Roi, France. minini@vjf.inserm.fr

Statistics in Medicine
|April 2, 2004
PubMed
Summary

This study introduces a sensitivity analysis method to assess how informative drop-outs affect longitudinal study results. The findings indicate that conclusions, such as treatment non-inferiority, remain robust even with potential drop-out biases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Venglustat in GM2 gangliosidoses and related disorders: Results of the AMETHIST randomized controlled and basket trials.

Genetics in medicine : official journal of the American College of Medical Genetics·2025
Same author

Clinical outcome assessments of disease burden and progression in late-onset GM2 gangliosidoses.

Molecular genetics and metabolism·2024
Same author

Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.

The Lancet. Neurology·2023
Same author

Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2022
Same author

Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial.

Brain : a journal of neurology·2022
Same author

The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD.

Kidney medicine·2022

Area of Science:

  • Biostatistics
  • Longitudinal Data Analysis
  • Clinical Trials

Background:

  • Longitudinal studies are susceptible to bias from informative drop-outs.
  • Assessing the impact of missing data due to drop-outs is crucial for result validity.

Purpose of the Study:

  • To develop and validate a sensitivity analysis method for informative drop-outs in longitudinal studies.
  • To evaluate the robustness of study conclusions under various drop-out scenarios.

Main Methods:

  • A selection model approach fixing the drop-out parameter to assess informativeness.
  • Computation of missing data expectation and variance conditional on drop-out time.
  • Application of a stochastic EM algorithm for maximum likelihood estimation.

Related Experiment Videos

Main Results:

  • Correctly specified drop-out parameters yield unbiased estimates and accurate confidence interval coverage.
  • Misspecification of the drop-out parameter showed minimal impact on results.
  • Sensitivity analysis confirmed non-inferiority conclusion in a clinical trial despite varying drop-out hypotheses.

Conclusions:

  • The proposed sensitivity analysis method effectively evaluates the impact of informative drop-outs.
  • Study conclusions, particularly non-inferiority in clinical trials, are robust to informative drop-out processes.